Source - SMW
The Biotech Growth Trust has reported that its net asset value per share rose by 27.5%, during the year ended 31 March 2017, compared to the Company's benchmark, the NASDAQ Biotechnology Index (sterling adjusted), which rose by 29.2%.

The share price rose by 27.9% over the period, which the Company said reflects a slight narrowing in the discount of the share price to net asset value per share, from 6.8% at the start of the year, to 6.6% at 31 March 2017.

At 1:53pm: (LON:BIOG) Biotech Gwth share price was +4.75p at 706.25p